- A close relationship betweenHelicobacter pyloriinfection and the serum level of CD47 in adults
Lei Feng et al, 2020, Scandinavian Journal of Gastroenterology CrossRef - Expression of CD47 and SIRPα Macrophage Immune-Checkpoint Pathway in Non-Small-Cell Lung Cancer
Alexandra Giatromanolaki et al, 2022, Cancers CrossRef - Prognostic significance of CKS2 and CD47 expression in patients with gastric cancer who underwent radical gastrectomy
Yang Zhou et al, 2022, Scandinavian Journal of Immunology CrossRef - Targeting HDAC6 improves anti-CD47 immunotherapy
Maria Gracia-Hernandez et al, 2024, Journal of Experimental & Clinical Cancer Research CrossRef - CD47: the next checkpoint target for cancer immunotherapy
Ridong Feng et al, 2020, Critical Reviews in Oncology/Hematology CrossRef - Is CD47 a potentially promising therapeutic target in cardiovascular diseases? — Role of CD47 in cardiovascular diseases
Quanli Cheng et al, 2020, Life Sciences CrossRef - Building on the backbone of CD47-based therapy in cancer: Combination strategies, mechanisms, and future perspectives
Zi-Han Ye et al, 2023, Acta Pharmaceutica Sinica B CrossRef - Hydrogen gas represses the progression of lung cancer via down-regulating CD47
Jinghong Meng et al, 2020, Bioscience Reports CrossRef - Advances in Anti-Tumor Treatments Targeting the CD47/SIRPα Axis
Wenting Zhang et al, 2020, Frontiers in Immunology CrossRef - The CD47-SIRPα axis is a promising target for cancer immunotherapies
Yu Hao et al, 2023, International Immunopharmacology CrossRef - CD47 is a Novel Potent Immunotherapy Target in Human Malignancies: Current Studies and Future Promises
Bing Tong et al, 2018, Future Oncology CrossRef - Combination of CD47 and signal‐regulatory protein‐α constituting the “don’t eat me signal” is a prognostic factor in diffuse large B‐cell lymphoma
Ryo Kazama et al, 2020, Cancer Science CrossRef - Selection and Characterization of FD164, a High-Affinity Signal Regulatory Protein α Variant with Balanced Safety and Effectiveness, from a Targeted Epitope Mammalian Cell-Displayed Antibody Library
Zhihong Wang et al, 2021, Molecular Pharmacology CrossRef - Co-targeting CD47 and VEGF elicited potent anti-tumor effects in gastric cancer
Kaiqi Zhang et al, 2024, Cancer Immunology, Immunotherapy CrossRef - Next generation of immune checkpoint inhibitors and beyond
Julian A. Marin-Acevedo et al, 2021, Journal of Hematology & Oncology CrossRef - CD47 expression and CD163+ macrophages correlated with prognosis of pancreatic neuroendocrine tumor
Rami Imam et al, 2021, BMC Cancer CrossRef - PD‐L1 and CD47 co‐expression predicts survival and enlightens future dual‐targeting immunotherapy in non‐small cell lung cancer
Zhenlin Yang et al, 2021, Thoracic Cancer CrossRef - Clinicopathological analysis of CD47 and signal regulatory protein alpha expression in myeloid sarcoma patients: CD47 expression is a favourable prognostic factor
Ken Tanaka et al, 2023, Pathology CrossRef - The overall potential of CD47 in cancer immunotherapy: with a focus on gastrointestinal tumors
Emmanouil Tzatzarakis et al, 2019, Expert Review of Anticancer Therapy CrossRef